UNITED STATES
Last updated: October 2026
This Global Healthcare Professional and Clinical Trial Site Personnel Privacy Notice (“HCP Notice”) explains how Jazz Pharmaceuticals plc and its corporate subsidiaries and affiliates (collectively “Jazz”, “we”, “us”, “our”) processes personal information (i.e. any information that could identify an individual either directly (e.g. name) or indirectly (e.g. a unique ID number)) about physicians, pharmacists, and other health care professionals with whom we interact in a business-related capacity and clinical investigators (principal investigators, sub-investigators or co-investigators) and site personnel (nurses, pharmacists or technicians, etc.) of clinical trials sponsored by Jazz (collectively, “HCPs”). It explains how we collect, disclose, use, and otherwise process personal information of HCPs and how HCPs can exercise their privacy rights.
HCPs located in certain jurisdictions, including the European Economic Area, United Kingdom, and Switzerland and residents of California have certain rights with respect to the collection, processing, and disclosure of their personal information. For more information, please see the “Additional Disclosures for HCPs in the EEA, UK, and Switzerland” section of this HCP Notice or the California Healthcare Professional and Clinical Trial Site Personnel Privacy Notice as applicable.
Please note that this HCP Notice does not apply to information we collect from non-HCP business contacts who interact with Jazz. For further details about our privacy practices pertaining to non-HCP personal information, please visit https://privacy.jazzpharma.com/.
Depending on locally applicable law, we may collect the following categories of personal information from HCPs:
You can choose not to give us the personal information listed above when we ask you for it. If you decide not to give us your personal information, we may not be able to continue in our business relationship or engagement with you, and you may not be able to work on clinical studies sponsored by Jazz (“Clinical Studies”), as applicable.
We will not process personal information (including any of the information listed above) if local law prohibits us from doing so.
We collect HCP personal information directly from HCPs. We may also collect HCP personal information from the following sources:
We may use your personal information for the following purposes:
We may also aggregate and/or deidentify HCP personal information and analyze those data for analytical, research, statistical, or any other purposes permitted by law. After it has been deidentified, the information is no longer personal information and is not subject to this HCP Notice.
Please note that, depending on locally applicable law, we may also process personal information via use of automated technologies, including artificial intelligence, for the purposes listed above. We may also use personal information we collect, as appropriate and to the extent permitted by applicable law, to train automated technologies we use for the above purposes.
We disclose the categories of personal information listed in this HCP Notice in the following contexts:
We may also disclose HCP personal information in the following contexts:
Given the global nature of Jazz's activities, your personal information may be transferred to countries located outside your home country or region, including to countries that may not have data protection laws equivalent to those in your home country. In such a case, we will implement appropriate measures to protect your personal information where required by and in accordance with the applicable data protection laws.
The security of your personal information is important to us. We take reasonable steps, including technical, administrative and physical safeguards, designed to protect the personal information submitted to us from loss, misuse and unauthorised access, disclosure, alteration and destruction. However, no method of security or method of transmission over the Internet is entirely secure. We therefore cannot guarantee that your personal information will not be disclosed, misused, or lost by accident or by the unauthorised acts of others. You should always use caution when transmitting personal information over the Internet.
We may retain your personal information for as long as your account is active or as needed for the specific business purpose for which it was collected. In some cases, we may be required to retain information for longer to comply with laws or regulations or other legal obligations, resolve disputes and enforce our agreements. Please note that in certain countries we may be required to retain Clinical Study Documentation for a minimum of 25 years.
This section provides additional information applicable to HCPs located in the European Economic Area (“EEA”), United Kingdom (“UK”), and Switzerland.
Data controller. Jazz Pharmaceuticals plc, with an office at Waterloo Exchange, Waterloo Road, Dublin 4, D04 E5W7, is the controller of your personal information, either independently or jointly.
Legal basis. We rely on the following legal basis to process HCP personal information under the GDPR and UK GDPR:
We only collect and process sensitive personal information if such processing is allowed or required under applicable law. In addition, we only process such sensitive personal information where (in addition to having a legal basis as set out above) it is necessary for the establishment, exercise, or defense of legal claims, where it is necessary for reasons of public interest in the area of public health, where we have obtained your explicit consent to process such data, or where we are required or allowed to do so under EU member state, UK, or Swiss data protection law, as applicable.
Automated decision-making. We do not rely solely on automated processing, including profiling, to make decisions that produce legal or similarly significant effects concerning you as an Applicant. If this changes, we will update this notice and provide all information required by applicable law.
Transfers of personal information outside the EEA, UK, and Switzerland. We may transfer your personal information to the United States or other countries outside of the EEA, UK or Switzerland. For the transfer of personal information from the EEA, UK or Switzerland to any countries not recognized by the European Commission, UK or Swiss governmental authorities as providing an adequate level of data protection according to EEA, UK or Swiss standards, we have implemented adequate measures to protect your personal information, such as by ensuring the recipient is bound by standard contractual clauses adopted by the European Commission, UK and Swiss governmental authorities. You can obtain information concerning such safeguards, including obtaining a copy of the standard contractual clauses, by contacting our data protection officer at dpo@jazzpharma.com.
All Jazz entities have entered into an Interaffiliate Data Processing and Transfer Agreement including Standard Contractual Clauses to govern the transfer of personal information within Jazz Pharmaceuticals from the EEA, the UK and Switzerland to other countries including the United States.
Data subject rights. HCPs located in the EEA, UK, and Switzerland have the following rights to their personal information, subject to certain exceptions.
For HCPs who work on our Clinical Studies, please note that due to the nature of the processing for scientific research purposes, not all of the above rights may be available to you. For example, personal information cannot be erased at the end of your involvement with the Clinical Study. If you withdraw from working on the clinical study, personal information collected up to your departure will be retained and processed to comply with legal obligations under applicable clinical study legislation, but no further personal information will be collected. We will consider any request and advise you if it is possible without affecting the Clinical Study data integrity.
You can make such a request by contacting us using any of the methods listed in the “How to contact us” section below. Please include your full name, email address, and relationship to Jazz, and type of request. We will respond to your request consistent with applicable law.
When you submit a request regarding your personal information, we reserve the right to verify your identity to help ensure that we provide the information we maintain to the individual to whom it pertains and allow only those individuals or their authorized representatives to exercise rights with respect to that information. Additionally, a person authorized to act on your behalf may make a verifiable request related to your personal information. If you designate an authorized person to submit requests to exercise certain privacy rights on your behalf, we will require verification that you provided the authorized person permission to make a request on your behalf.
If you feel your rights have been infringed as a result of the processing of your personal information in non-compliance with applicable data protection laws, you also have the right to lodge a complaint with your local data protection authority.
Data Protection Officer. If you have any questions about this HCP Notice or our privacy practices, please contact our Data Protection Officer at dpo@jazzpharma.com.
If you have any questions, comments or suggestions about this HCP Notice or our privacy practices, please contact the Jazz Pharmaceuticals Privacy Office at:
Address 3000 El Camino Real 2 Palo Alto Square, Suite 600 Palo Alto, CA 94306, U.S.
Tel.: (650) 496-3777
Email: privacy@jazzpharma.com
We may update this HCP Notice from time to time and will provide notice of such changes by updating the “Last Updated” date listed on this HCP Notice. If required by applicable law, we will provide you with additional notice if we make a material change to the HCP Notice, for example, by sending you an email or posting a banner on our websites.
Last Updated: October 02, 2026
The California Consumer Privacy Act, as amended by the California Privacy Rights Act, and its implementing regulations (collectively, the “CCPA”), gives California residents certain rights and requires businesses to make certain disclosures regarding their collection, use, and disclosure of personal information. This California Healthcare Professional and Clinical Trial Site Personnel Privacy Notice (“California HCP Notice”) supplements the Jazz Pharmaceuticals Global Healthcare Professional and Clinical Trial Site Personnel Privacy Notice and provides additional information about Jazz’s processing of personal information about HCPs who are residents of California.
Please note that this California HCP Notice does not apply to information we collect from non-HCP business contacts or to HCPs that are not California residents. For further details about our privacy practices pertaining to non-HCP personal information, please visit https://privacy.jazzpharma.com/.
Other terms used herein that are defined terms under the CCPA shall have the meanings afforded to them by the CCPA, whether or not capitalized, unless the context indicates otherwise.
We collect, and in the past 12 months have collected, the following categories of personal information from HCPs, in accordance with local law and per applicable consents:
We collect, process, and disclose, and in the past 12 months have collected, processed, and disclosed, the categories of personal information listed in Section II of this California HCP Notice for the following purposes:
Further, we collect, process, and disclose the categories of sensitive personal information described in this California HCP Notice only for purposes that are permitted by the CCPA regulations, including to perform the services or provide the goods reasonably expected by an average consumer who requests those goods or services and to perform services on behalf of the business.
We may also aggregate and/or deidentify HCP personal information and analyze those data for analytical, research, statistical, or any other purposes permitted by law. When we do so, we take reasonable measures to ensure that the information cannot be associated with an HCP or household, and we maintain and use the information in deidentified form. We will not attempt to reidentify the information, except that we may attempt to reidentify the information solely for the purpose of determining whether our deidentification processes satisfy applicable legal requirements. After it has been deidentified, the information is no longer personal information and is not subject to this California HCP Notice.
Please note that we may also process HCP personal information via use of automated technologies, including artificial intelligence, for the purposes listed above. To the extent permitted by applicable law, we may also use personal information we collect to train automated technologies we use for the above purposes. However, we do not process HCP personal information using automated decision making technologies to make significant decisions concerning HCPs.
We may retain your personal information for as long as your account is active or as needed for the specific business purpose for which it was collected. In some cases, we may be required to retain information for longer to comply with laws or regulations or other legal obligations, resolve disputes and enforce our agreements. Please note that in certain countries we may be required to retain Clinical Study Documentation for a minimum of 25 years.
Under the CCPA “Sell,” “Sale,” or “Sold” means renting, releasing, or transferring an individual’s personal information to a Third Party for money or other valuable consideration, and “Share,” “Shared,” or “Sharing” means transferring an individual’s personal information to a Third Party for cross-context behavioral advertising, whether or not for money or other valuable consideration. Accordingly, we Sell and Share and in the past 12 months have Sold and Shared, identifiers, such as IP addresses and other device identifiers, internet or other electronic network activity information, and inferences to third party marketing and analytics providers. We Sell and Share these categories of personal information for marketing and analytics purposes, including to analyze or predict consumer preferences to identify aggregated trends to develop, improve or modify our products, services and business activities and to deliver advertising, including interest-based advertising on our websites and applications and improving our advertising efforts. We do not otherwise “Sell” or “Share” other types of personal information we may collect about HCPs outside the cookie and online tracking technology context.
California HCPs have the right to opt-out of the Sale and Sharing of their personal information. To do so, click the “Your Privacy Choices” link in the footer of our websites and click “Reject All.”
We do not Sell or Share personal information of consumers we know, or reasonably should know, are under 18 years of age.
We disclose, and in the past 12 months have disclosed, the categories of HCP personal information listed in Section II of this California HCP Notice in the following contexts:
We may also disclose HCP personal information in the following contexts:
We collect HCP personal information directly from HCPs. We may also collect HCP personal information from the following sources:
As a California HCP, you have the following rights regarding our collection and use of your personal information, subject to certain exceptions.
Rights that Require Verification
Exercising the Rights to Know, Deletion, Correction, and Access Specific Pieces of PI: You can make such a request by calling (888) 249-7888, or by clicking here and filling out the Privacy Request Form. To verify your identity, we will match the information provided in the request to the information we have in our records. If necessary, we may ask the requestor to provide additional information to verify your identity and confirm that the request is valid. You may be able to authorize an agent to submit a request on your behalf. Authorized agents may submit a request in the same manner as an HCP, as listed above. When you use an authorized agent, we may ask the authorized agent to provide a copy of the HCP’s signed permission authorizing the agent to act on the HCP’s behalf, and in certain circumstances, we may ask you to verify your own identity directly with us. In some instances, we may decline to honor your request if an exception applies under applicable law. We will respond to your request consistent with applicable law.
Rights that Do Not Require Verification
Opt-Out Preference Signals: We recognize opt-out preference signals that we are required to recognize for compliance with applicable law. Where required by the CCPA, we treat such opt-out preference signals as a valid request to opt-out of Sale and Sharing for the browser or device through which the signal is sent and any consumer profile we have associated with that browser or device, including pseudonymous profiles. Further, if we know the identity of the consumer from the opt-out preference signal, we will also treat the opt-out preference signal as a valid request to opt out of Sale and Sharing for such consumer. Consumers may use opt-out preference signals by downloading or otherwise activating them for use on supported browsers and setting them to send opt-out preference signals to websites they visit. However, our sites do not respond to the “Do Not Track” signal, which is different from the opt-out preference signals described above.
Non-Retaliation: You have the right not to receive discriminatory treatment for the exercise of these rights. For example, we will not deny goods or services to you, or charge you different prices or rates, or provide a different level of quality for products or services as a result of you exercising your data subject rights.
We may update this California HCP Notice from time to time and will provide notice of such changes by updating the “Last Updated” date listed on this California HCP Notice. If required by applicable law, we will provide you with additional notice if we make a material change to the California HCP Notice, for example, by sending you an email or posting a banner on our websites.
If you have any questions about this California HCP Notice or our privacy practices, please contact the Jazz Pharmaceuticals Privacy Office at:
Address: 3000 El Camino Real 2 Palo Alto Square, Suite 600 3170 Porter Drive, Palo Alto, CA 94306, U.S.
Tel.: (650) 496-3777; Toll Free: (888) 249-7888
Email: privacy@jazzpharma.com